Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Morales

Showing results (21-30 of 112) with videos related to

Pageof 12
Sort By:
HIV Medicine|September 20, 2022
Changing co-morbidity and increasing deprivation among people living with HIV: UK population-based cross-sectional studyPatricia McGettigan, Daniel R Morales, David Moreno-Martos, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 2, 2019
Facial palsy: when and why to refer for specialist careDaniel P Butler, Daniel R Morales, Karen Johnson, et al.
British Journal of Clinical Pharmacology|August 30, 2019
Impact of medicines regulatory risk communications in the UK on prescribing and clinical outcomes: Systematic review, time series analysis and meta-analysisChristopher J Weatherburn, Bruce Guthrie, Tobias Dreischulte, et al.
Eclinicalmedicine|May 2, 2022
Health conditions in adults with HIV compared with the general population: A population-based cross-sectional analysisDaniel R Morales, David Moreno-Martos, Nashaba Matin, et al.
Breathe (Sheffield, England)|March 7, 2019
How to validate a diagnosis recorded in electronic health recordsFrancis Nissen, Jennifer K Quint, Daniel R Morales, et al.
Clinical Drug Investigation|August 26, 2018
Indications for Systemic Fluoroquinolone Therapy in Europe and Prevalence of Primary-Care Prescribing in France, Germany and the UK: Descriptive Population-Based StudyDaniel R Morales, Jim Slattery, Luis Pinheiro, et al.
Heart (British Cardiac Society)|March 4, 2025
Health conditions in adults with atrial fibrillation compared with the general population: a population-based cross-sectional analysisThomas J Downes, Bruce Guthrie, David Moreno-Martos, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 9, 2021
Intolerance to Angiotensin Converting Enzyme Inhibitors in Asthma and the General Population: A UK Population-Based Cohort StudyDaniel R Morales, Brian J Lipworth, Peter T Donnan, et al.
BMC Cardiovascular Disorders|April 15, 2023
External validation of the QLifetime cardiovascular risk prediction tool: population cohort studyShona Livingstone, Daniel R Morales, Jacques Fleuriot, et al.
BMC Medicine|January 28, 2026
Eligibility of real-world patients for aspirin primary prevention trials in cardiovascular diseaseMichael Holder, Daniel R Morales, Peter Hanlon, et al.
Pageof 12

Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
HIV Medicine|September 20, 2022
Changing co-morbidity and increasing deprivation among people living with HIV: UK population-based cross-sectional studyPatricia McGettigan, Daniel R Morales, David Moreno-Martos, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 2, 2019
Facial palsy: when and why to refer for specialist careDaniel P Butler, Daniel R Morales, Karen Johnson, et al.
British Journal of Clinical Pharmacology|August 30, 2019
Impact of medicines regulatory risk communications in the UK on prescribing and clinical outcomes: Systematic review, time series analysis and meta-analysisChristopher J Weatherburn, Bruce Guthrie, Tobias Dreischulte, et al.
Eclinicalmedicine|May 2, 2022
Health conditions in adults with HIV compared with the general population: A population-based cross-sectional analysisDaniel R Morales, David Moreno-Martos, Nashaba Matin, et al.
Breathe (Sheffield, England)|March 7, 2019
How to validate a diagnosis recorded in electronic health recordsFrancis Nissen, Jennifer K Quint, Daniel R Morales, et al.
Clinical Drug Investigation|August 26, 2018
Indications for Systemic Fluoroquinolone Therapy in Europe and Prevalence of Primary-Care Prescribing in France, Germany and the UK: Descriptive Population-Based StudyDaniel R Morales, Jim Slattery, Luis Pinheiro, et al.
Heart (British Cardiac Society)|March 4, 2025
Health conditions in adults with atrial fibrillation compared with the general population: a population-based cross-sectional analysisThomas J Downes, Bruce Guthrie, David Moreno-Martos, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 9, 2021
Intolerance to Angiotensin Converting Enzyme Inhibitors in Asthma and the General Population: A UK Population-Based Cohort StudyDaniel R Morales, Brian J Lipworth, Peter T Donnan, et al.
BMC Cardiovascular Disorders|April 15, 2023
External validation of the QLifetime cardiovascular risk prediction tool: population cohort studyShona Livingstone, Daniel R Morales, Jacques Fleuriot, et al.
BMC Medicine|January 28, 2026
Eligibility of real-world patients for aspirin primary prevention trials in cardiovascular diseaseMichael Holder, Daniel R Morales, Peter Hanlon, et al.
Pageof 12